Skip to content

Clinical trials

Alzheimer Disease trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Country / region: Switzerland Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20071
20084
20093
20102
20111
20142
20153
20164
20176
20183
20191
20206
20213
20224
20234
20242
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated16
Recruiting8
Unknown status4
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Bern7
Hoffmann-La Roche5
Novartis Pharmaceuticals4
Pfizer4
University of Zurich3
Amoneta Diagnostics SAS2
Biogen2
Novartis2
Novo Nordisk A/S2
University Hospital, Basel, Switzerland2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease56
Cognitive Dysfunction16
Dementia7
Neurodegenerative Diseases4
Central Nervous System Diseases3
Memory Disorders3
Frontotemporal Dementia2
Lewy Body Disease2
Neurocognitive Disorders2
Plaque, Amyloid2

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.